124 related articles for article (PubMed ID: 2819875)
1. Demonstration of the asymmetric effect of CC-1065 on local DNA structure using a site-directed adduct in a 117-base-pair fragment from M13mp1.
Hurley LH; Needham-VanDevanter DR; Lee CS
Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6412-6. PubMed ID: 2819875
[TBL] [Abstract][Full Text] [Related]
2. Recognition and repair of the CC-1065-(N3-adenine)-DNA adduct by the UVRABC nucleases.
Tang MS; Lee CS; Doisy R; Ross L; Needham-VanDevanter DR; Hurley LH
Biochemistry; 1988 Feb; 27(3):893-901. PubMed ID: 2966637
[TBL] [Abstract][Full Text] [Related]
3. Construction and characterization of a site-directed CC-1065-N3-adenine adduct within a 117 base pair DNA restriction fragment.
Needham-VanDevanter DR; Hurley LH
Biochemistry; 1986 Dec; 25(26):8430-6. PubMed ID: 3030397
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of T4 DNA ligase activity by (+)-CC-1065: demonstration of the importance of the stiffening and winding effects of (+)-CC-1065 on DNA.
Sun D; Hurley LH
Anticancer Drug Des; 1992 Feb; 7(1):15-36. PubMed ID: 1543525
[TBL] [Abstract][Full Text] [Related]
5. Determination of the structural features of (+)-CC-1065 that are responsible for bending and winding of DNA.
Lee CS; Sun D; Kizu R; Hurley LH
Chem Res Toxicol; 1991; 4(2):203-13. PubMed ID: 1782349
[TBL] [Abstract][Full Text] [Related]
6. Determination of the major tautomeric form of the covalently modified adenine in the (+)-CC-1065-DNA adduct by 1H and 15N NMR studies.
Lin CH; Hurley LH
Biochemistry; 1990 Oct; 29(41):9503-7. PubMed ID: 2271598
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of (+)-CC-1065 analogues in the inhibition of helicase-catalyzed unwinding of duplex DNA.
Sun D; Hurley LH
J Med Chem; 1992 May; 35(10):1773-82. PubMed ID: 1588557
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an adduct between CC-1065 and a defined oligodeoxynucleotide duplex.
Needham-VanDevanter DR; Hurley LH; Reynolds VL; Theriault NY; Krueger WC; Wierenga W
Nucleic Acids Res; 1984 Aug; 12(15):6159-68. PubMed ID: 6473105
[TBL] [Abstract][Full Text] [Related]
9. Effect of the (+)-CC-1065-(N3-adenine)DNA adduct on in vitro DNA synthesis mediated by Escherichia coli DNA polymerase.
Sun D; Hurley LH
Biochemistry; 1992 Mar; 31(10):2822-9. PubMed ID: 1547223
[TBL] [Abstract][Full Text] [Related]
10. Structure of the (+)-CC-1065-DNA adduct: critical role of ordered water molecules and implications for involvement of phosphate catalysis in the covalent reaction.
Lin CH; Beale JM; Hurley LH
Biochemistry; 1991 Apr; 30(15):3597-602. PubMed ID: 2015216
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a common molecular basis for sequence recognition of N3-guanine and N3-adenine DNA adducts involving the covalent bonding reaction of (+)-CC-1065.
Park HJ
Arch Pharm Res; 2002 Feb; 25(1):11-24. PubMed ID: 11885687
[TBL] [Abstract][Full Text] [Related]
12. Reaction of the antitumor antibiotic CC-1065 with DNA. Location of the site of thermally induced strand breakage and analysis of DNA sequence specificity.
Reynolds VL; Molineux IJ; Kaplan DJ; Swenson DH; Hurley LH
Biochemistry; 1985 Oct; 24(22):6228-37. PubMed ID: 3002434
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis for sequence-specific DNA alkylation by CC-1065.
Hurley LH; Lee CS; McGovren JP; Warpehoski MA; Mitchell MA; Kelly RC; Aristoff PA
Biochemistry; 1988 May; 27(10):3886-92. PubMed ID: 3408734
[TBL] [Abstract][Full Text] [Related]
14. An NMR study of the covalent and noncovalent interactions of CC-1065 and DNA.
Scahill TA; Jensen RM; Swenson DH; Hatzenbuhler NT; Petzold G; Wierenga W; Brahme ND
Biochemistry; 1990 Mar; 29(11):2852-60. PubMed ID: 2346749
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for sequence selective DNA alkylation by (+)- and ent-(-)-CC-1065 and related agents: alkylation site models that accommodate the offset AT-rich adenine N3 alkylation selectivity.
Boger DL; Johnson DS; Yun W; Tarby CM
Bioorg Med Chem; 1994 Feb; 2(2):115-35. PubMed ID: 7922122
[TBL] [Abstract][Full Text] [Related]
16. (+)-CC-1065 as a structural probe of Mu transposase-induced bending of DNA: overcoming limitations of hydroxyl-radical footprinting.
Ding ZM; Harshey RM; Hurley LH
Nucleic Acids Res; 1993 Sep; 21(18):4281-7. PubMed ID: 8414983
[TBL] [Abstract][Full Text] [Related]
17. (+)-CC-1065 as a probe for intrinsic and protein-induced bending of DNA.
Hurley LH; Sun D
J Mol Recognit; 1994 Jun; 7(2):123-32. PubMed ID: 7826672
[TBL] [Abstract][Full Text] [Related]
18. Binding of Sp1 to the 21-bp repeat region of SV40 DNA: effect of intrinsic and drug-induced DNA bending between GC boxes.
Sun D; Hurley LH
Gene; 1994 Nov; 149(1):165-72. PubMed ID: 7958981
[TBL] [Abstract][Full Text] [Related]
19. Sequence-dependent interactions of two forms of UvrC with DNA helix-stabilizing CC-1065-N3-adenine adducts.
Nazimiec M; Lee CS; Tang YL; Ye X; Case R; Tang M
Biochemistry; 2001 Sep; 40(37):11073-81. PubMed ID: 11551204
[TBL] [Abstract][Full Text] [Related]
20. DNA interstrand cross-linking, DNA sequence specificity, and induced conformational changes produced by a dimeric analog of (+)-CC-1065.
Ding ZM; Hurley LH
Anticancer Drug Des; 1991 Nov; 6(5):427-52. PubMed ID: 1662513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
